
Singaporean Biotech Startup Gero Raises US$2.2M Series A To Deliver Anti-Aging Solutions
Gero’s Series A will help further develop the proprietary AI platform to identify treatments for aging-related and other diseases Singapore-based Biotech startup Gero, which develops














